Inventor

Gregor Bahrenberg

Inventor
Monschau, DE

Overview

46→
Patents
2006–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds5%
C12NMicroorganisms or enzymes1%
PatentTitleYear
10,265,3106-membered cyclic amines or lactames substituted with urea and phenyl20199,775,843'Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders'20179,771,359'Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II'20179,624,209'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20179,284,286'Specific carboxamides as KCNQ2/3 modulators'20169,278,103'Substituted 6-amino-nicotinamides as KCNQ2/3 modulators'20169,248,122'Heteroquinoline-3-carboxamides as KCNQ2/3 modulators'20169,168,259'Substituted 6-amino-nicotinamides as KCNQ2/3 modulators'20159,120,756'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20159,108,936'Substituted 4-aminobenzamides as KCNQ2/3 modulators'20159,073,862'Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators'20158,946,204'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20158,937,092'Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands'20158,791,268'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions'20148,785,474'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions'20148,772,307'Substituted spiro compounds and their use for producing pain-relief medicaments'20148,765,733'Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands'20148,735,426'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions'20148,710,233'Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations'20148,653,102'Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators'20148,653,101'Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators'20148,642,775'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions'20148,642,623'Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions'20148,618,129'Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators'20138,592,471'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20138,586,755'Substituted nicotinamides as KCNQ2/3 modulators'20138,552,200'Substituted 6-amino-nicotinamides as KCNQ2/3 modulators'20138,470,852'Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators'20138,445,512'Substituted quinoline-3-carboxamides as KCNQ2/3 modulators'20138,399,673'Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators'20138,367,700'Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators'20138,334,315'Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands'20128,288,424'Substituted tetrahydroimidazopyridine compounds and the use thereof in the treatment of pain and other conditions'20128,252,816'Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions'20128,247,573'Substituted N-(2-mercaptopyridin-3-yl)amides as KCNQ2/3 modulators'20128,207,342'Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators'20128,178,684'Substituted nicotinamides as KCNQ2/3 modulators'20128,084,484'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions'20118,084,470'Substituted nicotinamide compounds and uses thereof'20118,017,772'Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain'20117,981,883'Substituted spiro-compounds and the use thereof for producing medicaments'20117,879,858'Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions'20117,879,991'CGRP binding nucleic acids'20117,696,238'Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics'20107,625,900'Sutstituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain'20097,109,214'Substituted cyclopentene compounds'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2014Based in Aachen, DE· patent location history
2009–2019Patents assigned to GRUENENTHAL GMBH (43)· patent assignee history
2011–2015Patents assigned to BAHRENBERG GREGOR (27)· patent assignee history
2011–2014Patents assigned to KUEHNERT SVEN (14)· patent assignee history
2011–2015Patents assigned to FRANK ROBERT (13)· patent assignee history
2011–2015Patents assigned to SCHIENE KLAUS (13)· patent assignee history
2011–2019Based in Monschau, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GRUENENTHAL GMBH432009–2019
BAHRENBERG GREGORself272011–2015
KUEHNERT SVEN142011–2014
FRANK ROBERT132011–2015
SCHIENE KLAUS132011–2015
Locations
LocationPatentsSpan
Monschau, DE302011–2019
Aachen, DE162006–2014